1. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial. (9th February 2021) Authors: Bril, Vera; Benatar, Michael; Andersen, Henning; Vissing, John; Brock, Melissa; Greve, Bernhard; Kiessling, Peter; Woltering, Franz; Griffin, Laura; Van den Bergh, Peter Other Names: Benarik Josef author non-byline.; Beydoun Said author non-byline.; Blaes Franz author non-byline.; De Bleecker Jan author non-byline.; Freimer Miriam author non-byline.; Genge Angela author non-byline.; Grosskreutz Julian author non-byline.; Guerrero Sola Antonio author non-byline.; Guptill Jeffr... Journal: Neurology Issue: Volume 96:Number 6(2021) Page Start: e853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗